Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis

Published:2011-05-13 Issue:5 Volume:6 Page:e19262
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rudick Richard A.,Rani M. R. Sandhya,Xu Yaomin,Lee Jar-Chi,Na Jie,Shrock Jennifer,Josyula Anupama,Fisher Elizabeth,Ransohoff Richard M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. the multiple sclerosis collaborative research group (MSCRG).;LD Jacobs;Ann Neurol,1996

2. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis.;Lancet,1998

3. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. clinical results of a multicenter, randomized, double-blind, placebo-controlled trial.;Neurology,1993

4. Defining interferon beta response status in multiple sclerosis patients.;RA Rudick;Ann Neurol,2004

5. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.;J Rio;Mult Scler,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Icariin ameliorates the cuprizone-induced demyelination associated with antioxidation and anti-inflammation;Inflammopharmacology;2024-01-04

2. Bayesian approach for predicting responses to therapy from high-dimensional time-course gene expression profiles;BMC Bioinformatics;2021-03-18

3. Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection;EBioMedicine;2019-11

4. Pharmacogenomics of Multiple Sclerosis: A Systematic Review;Frontiers in Neurology;2019-02-26

5. Elastic net-based prediction of IFN-β treatment response of patients with multiple sclerosis using time series microarray gene expression profiles;Scientific Reports;2019-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3